切换至 "中华医学电子期刊资源库"
高级检索
中华结直肠疾病电子杂志

中华结直肠疾病电子杂志 ›› 2024, Vol. 13 ›› Issue (04) : 288 -293. doi: 10.3877/cma.j.issn.2095-3224.2024.04.004

论著

纳米炭导航行淋巴示踪在结直肠癌TNM分期中淋巴分期价值的临床研究
戈伟1, 陈刚1,†()   
  1. 1. 210008　南京大学医学院附属鼓楼医院结直肠外科
  • 收稿日期:2024-05-14 出版日期:2024-08-25
  • 通信作者: 陈刚
  • 基金资助:
    南京鼓楼医院临床研究专项资金资助项目(2021-LCYJ-MS-14)

Clinical research on the value of carbon nanoparticles navigation lymphatic tracing in TNM staging of colorectal cancer

Wei Ge1, Gang Chen1,†()   

  1. 1. Department of Colorectal Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China
  • Received:2024-05-14 Published:2024-08-25
  • Corresponding author: Gang Chen
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

戈伟, 陈刚. 纳米炭导航行淋巴示踪在结直肠癌TNM分期中淋巴分期价值的临床研究[J]. 中华结直肠疾病电子杂志, 2024, 13(04): 288-293.

Wei Ge, Gang Chen. Clinical research on the value of carbon nanoparticles navigation lymphatic tracing in TNM staging of colorectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(04): 288-293.

目的

探索纳米炭混悬注射液在结直肠癌TNM分期中淋巴分期的临床价值。

方法

南京大学医学院附属鼓楼医院结直肠外科自2021年7月起，开展了一项前瞻性、随机对照临床试验。患者筛选合格后，随机分配到试验组和对照组，计划纳入每组可评价病例200例。试验组患者由研究者行肠镜检查，并注射纳米炭混悬液。对照组患者常规进行手术，术前不注射纳米炭混悬液。比较两组之间淋巴结检出数、阳性淋巴结检出数、淋巴分期之间的差异。

结果

共361例患者纳入临床研究，其中试验组179例，对照组182例。试验组患者获取的淋巴结总数平均为（20.2±5.9）枚，高于对照组的（15.0±5.5）枚，差异有统计学意义（t=8.584，P<0.001）。试验组患者获取的阳性淋巴结总数平均为（1.6±3.9）枚，高于对照组的（0.8±1.9）枚，差异有统计学意义（t=2.852，P=0.005）。试验组中，97例患者（54.2%）淋巴分期为N0，56例患者（31.3%）为N1，26例患者（14.5%）为N2。对照组中，115例患者（63.2%）淋巴分期为N0，57例患者（31.3%）为N1，10例患者（5.5%）为N2。两组之间淋巴分期的差异有统计学意义（χ2=8.624，P=0.013）。

结论

结直肠癌行纳米炭淋巴示踪导航可以获取更多的淋巴结和阳性淋巴结，从而得到更精准、更客观的淋巴分期，判断预后，指导后续治疗方案。

关键词: 结直肠肿瘤, 纳米炭, 淋巴示踪, 淋巴分期, 导航
Objective

To explore the clinical value of carbon nanocomposite suspension injection in TNM staging of colorectal cancer.

Methods

A prospective, randomized, controlled clinical trial was conducted in July 2021 in the Department of Colorectal Surgery, Nanjing Drum Tower Hospital. After the patients were qualified, they were randomly assigned to study group and control group, and 200 evaluable cases were planned to be included in each group. The patients in the study group underwent colonoscopy and were injected with carbon nanocomposite suspension. The patients in the control group were treated with routine operation, and no carbon nano-suspension was injected before operation. The number of lymph nodes detected, the number of positive lymph nodes detected and the lymph stages were compared between the two groups.

Results

A total of 361 patients were enrolled in the clinical study, including 179 patients in the study group and 182 patients in the control group. The total number of lymph nodes obtained in the study group was 20.2±5.9, which was significantly higher than that in the control group (15.0±5.5) (t=8.584, P<0.001). The total number of positive lymph nodes in the study group was 1.6±3.9, which was significantly higher than that in the control group (0.8±1.9)(t=2.852, P=0.005). In the study group, 97 patients (54.2%) were N0, 56 patients (31.3%) were N1, and 26 patients (14.5%) were N2. In the control group, 115 patients (63.2%) were N0, 57 patients (31.3%) were N1, and 10 patients (5.5%) were N2. There was significant difference in lymph staging between the two groups (χ2=8.624, P=0.013).

Conclusion

The application of nano-carbon in lymph node tracing navigation for colorectal cancer can obtain more lymph nodes and positive lymph nodes, and thus obtain more accurate and objective lymph node staging, judge prognosis and guide follow-up treatment plan.

Key words: Colorectal neoplasms, Carbon nanoparticles, Lymphatic tracing, Lymphatic staging, Navigation
表1 入组患者的一般临床参数
变量 试验组（n=179） 对照组（n=182） t/χ2值 P值
年龄（岁） 62.9±10.5 63.2±10.7 0.193 0.847
性别 0.045 0.913
男 116 116
女 63 66
诊断 2.92 0.102
乙状结肠癌 39 27
直肠癌 140 155
手术方式 0.163 0.722
腹腔镜 175 179
开放 4 3
肿瘤最大径（cm） 3.31±0.99 3.67±1.11 0.878 0.380
术中标本切除的长度（cm） 15.1±2.2 15.5±2.2 1.193 0.234
T分期 2.037 0.361
T1 37 49
T2 109 100
T3 33 33
手术时间（分钟） 175±18 170±19 -0.190 0.849
出血量（mL） 83±34 80±38 -0.924 0.357
住院时间（天） 11.8±1.7 12.0±1.9 -0.130 0.886
图1 肠系膜内可见黑染的淋巴结
表2 试验组与对照组获取的淋巴结总数的比较（）
分类 试验组 对照组 t值 P值
淋巴结获取的总数 20.2±5.9 15.0±5.5 8.584 <0.001
阳性淋巴结获取总数 1.6±3.9 0.8±1.9 2.852 0.005
253组淋巴结获取的总数 2.2±3.0 1.6±2.0 2.475 0.014
阳性253组淋巴结获取总数 0.07±0.49 0.00±0.00 2.106 0.045
表3 两组之间淋巴分期及TNM分期的比较[例（%）]
分期 试验组（n=179） 对照组（n=182） χ2值 P值
N分期 8.624 0.013
N0 97（54.2） 115（63.2）
N1 56（31.3） 57（31.3）
N2 26（14.5） 10（5.5）
TNM分期 6.340 0.042
Ⅰ 38（21.2） 58（31.9）
Ⅱ 58（32.4） 59（32.4）
Ⅲ 83（46.4） 65（35.7）
[1]
Zeng H, Xue X, Chen D, et al. Conditional survival analysis and real-time prognosis prediction in stage III T3-T4 colon cancer patients after surgical resection: a SEER database analysis[J]. Int J Colorectal Dis, 2024, 39(1): 54.
[2]
Koimtzis G, Geropoulos G, Stefanopoulos L, et al. The role of carbon nanoparticles as lymph node tracers in colorectal cancer: a systematic review and meta-analysis[J]. Int J Mol Sci, 2023, 24(20): 15293.
[3]
Fang YC, Wang YZ, Wu WH, et al. Application value of the carbon nanoparticles-titanium clip labeling technique for resection of Siewert type Ⅱ adenocarcinoma of the esophagogastric junction[J]. Chin J Gastrointest Surg, 2024, 27(3): 274-277.
[4]
Chen Y, Zhang S, Miao K, et al. Evaluating the effectiveness of dual dye combination of indocyanine green and carbon nanoparticles with parathyroid hormone test in preserving parathyroid gland during papillary thyroid cancer surgery: a single-center retrospective cohort study[J]. Updates Surg, 2024, 76(3): 1063-1071.
[5]
Zhao J, Wang J, Cheng R, et al. Safety and effectiveness of carbon nanoparticles suspension-guided lymph node dissection during thyroidectomy in patients with thyroid papillary cancer: a prospective, multicenter, randomized, blank-controlled trial[J]. Front Endocrinol (Lausanne), 2024, (14): 1251820.
[6]
Li Z. Lymph node mapping in rabbit liver cancer with nanocarbon and methylene blue injecta[J]. Asian Pac J Trop Med, 2013, 6(5): 400-403.
[7]
Wang R, Mo S, Liu Q, et al. The safety and effectiveness of carbon nanoparticles suspension in tracking lymph node metastases of colorectal cancer: a prospective randomized controlled trial[J]. Jpn J Clin Oncol, 2020, 50(5): 535-542.
[8]
Zuo J, Wu LY, Cheng M, et al. Comparison study of laparoscopic sentinel lymph node mapping in endometrial carcinoma using carbon nanoparticles and lymphatic pathway verification[J]. J Minim Invasive Gynecol, 2019, 26(6): 1125-1132.
[9]
Yang SX, Wei WS, Jiang QH, et al. Analysis of 246 sentinel lymph node biopsies of patients with clinical primary breast cancer by application of carbon nanoparticle suspension[J]. J Obstet Gynaecol Res, 2018, 44(6): 1150-1157.
[10]
Zhao Y, Han G, Li J, et al. Technical advantages of nano carbon development combined with artery approach in lymph node sorting of rectal cancer[J]. Chin J Gastrointest Surg, 2017, 20(6): 680-683.
[11]
Chen Z, Zhong Z, Chen G, et al. Application of carbon nanoparticles in neck dissection of clinically node-negative papillary thyroid carcinoma[J]. Biomed Res Int, 2021, 2021: 6693585.
[12]
Ya X, Qian W, Huiqing L, et al. Role of carbon nanoparticle suspension in sentinel lymph node biopsy for early-stage cervical cancer: a prospective study[J]. BJOG, 2021, 128(5): 890-898.
[13]
Zhang L, Huang Y, Yang C, et al. Application of a carbon nanoparticle suspension for sentinel lymph node mapping in patients with early breast cancer: a retrospective cohort study[J]. World J Surg Oncol, 2018, 16(1): 112.
[14]
Zhang XM, Liang JW, Wang Z, et al. Effect of preoperative injection of carbon nanoparticle suspension on the outcomes of selected patients with mid-low rectal cancer[J]. Chin J Cancer, 2016, (35): 33.
[15]
Wang Y, Deng H, Chen H, et al. Preoperative submucosal injection of carbon nanoparticles improves lymph node staging accuracy in rectal cancer after neoadjuvant chemoradiotherapy[J]. J Am Coll Surg, 2015, 221(5): 923-930.
[16]
Pan L, Ye F, Liu JJ, et al. A study of using carbon nanoparticles to improve lymph nodes staging for laparoscopic-assisted radical right hemicolectomy in colon cancer[J]. Int J Colorectal Dis, 2018, 33(8): 1131-1134.
[1] 张江礼, 刘金辉, 潘西庆, 刘光源, 范虓. 全膝关节置换应用智能辅助手术导航系统治疗膝骨关节炎[J]. 中华关节外科杂志(电子版), 2024, 18(03): 346-351.
[2] 陈金业, 凌潜龙, 朱冰, 骆杰. 补体B因子在结直肠癌中的表达及临床意义[J]. 中华普通外科学文献(电子版), 2024, 18(03): 192-198.
[3] 孙姚承, 汤建军, 张伟元, 刘传磊. 阳性淋巴结比和阳性淋巴结对数比对结直肠癌患者预后价值的研究[J]. 中华普通外科学文献(电子版), 2024, 18(03): 204-208.
[4] 谢丽春, 欧庆芬, 张秋萍, 叶升. 简化和标准肝脏MRI方案在结直肠癌肝转移患者随访中的临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 434-437.
[5] 施烨鑫, 马翔, 鲁明, 夏青城, 王鹏超, 宋青雨, 赵庆洪. 腹腔镜下结直肠肿瘤定位研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 463-466.
[6] 牛斌, 饶兰英, 刘晓晨, 何龙林, 秦培鑫. 基于孟德尔随机化分析胆囊切除与结直肠肛管恶性肿瘤发生的关系[J]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 313-318.
[7] 季鹏程, 鄂一民, 陆晨, 喻春钊. 循环外泌体相关生物标志物在结直肠癌诊断中的研究进展[J]. 中华结直肠疾病电子杂志, 2024, 13(04): 265-273.
[8] 李佳莹, 王旭丹, 梁雪, 张雷, 李佳英. 1990~2021年中国结直肠癌死亡趋势分析[J]. 中华结直肠疾病电子杂志, 2024, 13(04): 274-279.
[9] 崔精, 鲍一帆, 沈晓明, 杨增辉, 高森, 鲍传庆. 结直肠癌中circMFSD12对肿瘤细胞功能及5-FU敏感性的调控[J]. 中华结直肠疾病电子杂志, 2024, 13(04): 294-302.
[10] 李月刚, 关旭, 赵志勋, 权继传, 庄孟, 汤坚强. 结直肠癌NOSES手术的国际研究现状[J]. 中华结直肠疾病电子杂志, 2024, 13(04): 321-328.
[11] 国超凡, 彭琪博, 郑章强, 于向阳. 低位前切除综合征风险预测及治疗的研究进展[J]. 中华结直肠疾病电子杂志, 2024, 13(04): 335-340.
[12] 杨明, 张金珠, 王锡山. 全国肿瘤登记中心发布的2013年至2022年结直肠癌流行数据趋势解读[J]. 中华结直肠疾病电子杂志, 2024, 13(03): 177-181.
[13] 黄胜辉, 阮浩杨. 降结肠系膜旋转不良合并结直肠癌的腹腔镜手术策略[J]. 中华结直肠疾病电子杂志, 2024, 13(03): 182-188.
[14] 张继新, 谢爽, 王雪莲, 武祖印, 梁延洋, 张春旭. 经鼻插入肠梗阻导管联合NOSES微创治疗梗阻性结直肠癌的研究[J]. 中华结直肠疾病电子杂志, 2024, 13(03): 189-196.
[15] 张金珠, 梅世文, 孙金峰, 胡刚, 邱文龙, 李国利, 汪欣, 王锡山, 汤坚强. 原发结直肠癌超系膜切除术后患者的生存危险因素分析[J]. 中华结直肠疾病电子杂志, 2024, 13(03): 197-204.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号